Procalcitonin as an effective biomarker for the diagnosis and prognosis of severe sepsis. Highlights from the 25th International Symposium on Intensive Care and Emergency Medicine. March 21-25, 2005, Brussels, Belgium.

Autor: Sorbera LA; Prous Science, Barcelona, Spain. journals@prous.com
Jazyk: angličtina
Zdroj: Drugs of today (Barcelona, Spain : 1998) [Drugs Today (Barc)] 2005 Apr; Vol. 41 (4), pp. 253-6.
DOI: 10.1358/dot.2005.41.4.900160
Abstrakt: Several reports presented at the 25th International Symposium on Intensive Care and Emergency Medicine held March 21-25 in Brussels, Belgium, have demonstrated the efficacy of using the prohormone procalcitonin (PCT) as a biomarker for severe sepsis. This article reviews some of the most exciting studies.
Databáze: MEDLINE